Ryan Cole
Net worth: 2 M $ as of 29/09/2026
Net worth: 2 M $ as of 29/09/2026
Mr. Ryan Cole, CPA, is a Chief Operating Officer at Tang Capital Acquisition Corp., a Chief Operating Officer at Kezar Life Sciences, Inc. and a Chief Operating Officer at Aurinia Pharmaceuticals, Inc. Mr. Cole was previously employed as a Senior Vice President-Operations by Odonate, Inc. and a Senior Auditor by Ernst & Young LLP.
He received his undergraduate degree from Santa Clara University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/05/2026 | 116,144 ( 0.09% ) | 2 M $ | 29/09/2026 |
| Companies | Position | Start |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chief Operating Officer | 22/03/2026 |
| KEZAR LIFE SCIENCES, INC. | Chief Operating Officer | 10/05/2026 |
| Companies | Position | End |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 30/04/2012 |
| ODONATE, INC. | Chief Operating Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions